Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Elliott

Immunotherapy advances

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Immunotherapy Advances|April 23, 2025
Imaging antigen processing and presentation in cancerDoreen Lau, Tim Elliott
Immunotherapy Advances|March 22, 2021
Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cellsGessa Sugiyarto, David Prossor, Osman Dadas, et al.
Immunotherapy Advances|September 30, 2022
De-risking clinical trial failure through mechanistic simulationLiam V Brown, Jonathan Wagg, Rachel Darley, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Immunotherapy Advances|April 23, 2025
Imaging antigen processing and presentation in cancerDoreen Lau, Tim Elliott
Immunotherapy Advances|March 22, 2021
Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cellsGessa Sugiyarto, David Prossor, Osman Dadas, et al.
Immunotherapy Advances|September 30, 2022
De-risking clinical trial failure through mechanistic simulationLiam V Brown, Jonathan Wagg, Rachel Darley, et al.
Pageof 1